On April 9, Lt. Governor Jon Husted announced that The Christ Hospital Lindner Research Center in Cincinnati has received approval from the U.S. Food and Drug Administration to begin treating high-risk COVID-19 patients with convalescent plasma.
This treatment protocol is the only protocol that incorporates a readily available, rapid turnaround (less than 1 hour) blood test that reflects risk of dying and can identify patients before it’s too late.
“Hospitals in Cincinnati, Columbus, and Cleveland have all expressed interest in participating in the treatment protocol,” said Lt. Governor Husted. “This is another great step in our efforts to save lives.”